New perspectives drive paradigms in dry eye diagnosis, treatment

Article

Recent research has created new perspectives on tear film dysfunction and ocular surface disease that is driving the development of new therapeutic concepts along with innovations in diagnosis and treatment.

Key Points

Orlando, FL-Recent research has created new perspectives on tear film dysfunction and ocular surface disease that is driving the development of new therapeutic concepts along with innovations in diagnosis and treatment, said Arthur B. Epstein, OD, at the annual meeting of the American Academy of Optometry.

He explained that the ocular surface and tear film can be thought of as a unique external environment created by the body. However, it is a complex microenvironment that consists of multiple components and that is continuously exposed to potentially disrupting factors within a macroenvironment.

Defects in the lipid, aqueous, and mucin components of the tear film can precipitate dry eye disease.

"Breakdown in the lipid, aqueous, or mucin components of the tear film can lead to dry eye, and the precipitating factor doesn't matter. Regardless of what that is, a perpetuating cyclic process is induced that leads to inflammation. Inflammation as a feature of dry eye disease develops as a last-ditch compensatory effort to fix a disrupted environment," he said.

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Devin Sasser, OD, shares his excitement for Acuvue Oasys MAX 1-Day multifocal for astigmatism, the first and only daily disposable multifocal toric contact lens.
Reviewing the State of Dry Eye Survey with Selina McGee, OD, FAAO, Dipl ABO
Jessilin Quint, OD, MBA, FAAO, outlines her AOA's Optometry's Meeting 2025 presentation on nutrition and its impact on ocular health.
Carolyn Majcher, OD, FAAO, detailed a talk she gave alongside Mary Beth Yackey, OD, at Optometry's Meeting 2025.
Shelby Brogdon, OD, details opportunities for practices to answer the patient's concerns from the chair before they hit the internet for their contact lens needs.
Christi Closson, OD, FAAO, shares her excitement for the new Acuvue Oasys MAX 1-Day multifocal for astigmatism
Karen R. Hoffman, OD, shares how customizable scleral lenses can transform vision for patients with complex corneas, achieving 20/20 outcomes and enhanced comfort.
Janna Pham, OD, shares key takeaways from a corneal tomography session she presented alongside Travis Pfeifer, OD; and Matthew McGee, OD.
Jacob Lang, OD, FAAO, details early symptom relief demonstrated in as early as day 1 during AOA's Optometry's Meeting 2025.
When Langis Michaud, OD, MSc, FAAO, FSLS, FBCLA, FEAOO, began fitting scleral lenses 20 years ago, there was limited knowledge about conjunctival characteristics, scleral shape, and lens behavior.
© 2025 MJH Life Sciences

All rights reserved.